NewAmsterdam Pharma Co NV (NAMS)
16.23
+0.40
(+2.53%)
USD |
NASDAQ |
Sep 27, 16:00
16.26
+0.04
(+0.22%)
After-Hours: 20:00
NewAmsterdam Pharma Enterprise Value: 1.030B for Sept. 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 27, 2024 | 1.030B |
| September 26, 2024 | 994.24M |
| September 25, 2024 | 941.13M |
| September 24, 2024 | 969.03M |
| September 23, 2024 | 961.83M |
| September 20, 2024 | 1.002B |
| September 19, 2024 | 1.015B |
| September 18, 2024 | 1.005B |
| September 17, 2024 | 960.03M |
| September 16, 2024 | 995.14M |
| September 13, 2024 | 1.006B |
| September 12, 2024 | 1.010B |
| September 11, 2024 | 1.024B |
| September 10, 2024 | 1.052B |
| September 09, 2024 | 1.089B |
| September 06, 2024 | 1.046B |
| September 05, 2024 | 1.028B |
| September 04, 2024 | 1.011B |
| September 03, 2024 | 1.001B |
| August 30, 2024 | 1.047B |
| August 29, 2024 | 1.019B |
| August 28, 2024 | 1.037B |
| August 27, 2024 | 1.079B |
| August 26, 2024 | 1.078B |
| August 23, 2024 | 1.033B |
| Date | Value |
|---|---|
| August 22, 2024 | 1.057B |
| August 21, 2024 | 1.034B |
| August 20, 2024 | 1.030B |
| August 19, 2024 | 1.055B |
| August 16, 2024 | 1.012B |
| August 15, 2024 | 1.045B |
| August 14, 2024 | 1.100B |
| August 13, 2024 | 1.119B |
| August 12, 2024 | 1.103B |
| August 09, 2024 | 1.135B |
| August 08, 2024 | 1.091B |
| August 07, 2024 | 978.93M |
| August 06, 2024 | 1.030B |
| August 05, 2024 | 1.004B |
| August 02, 2024 | 1.101B |
| August 01, 2024 | 1.123B |
| July 31, 2024 | 1.110B |
| July 30, 2024 | 1.026B |
| July 29, 2024 | 1.122B |
| July 26, 2024 | 1.267B |
| July 25, 2024 | 1.254B |
| July 24, 2024 | 1.270B |
| July 23, 2024 | 1.274B |
| July 22, 2024 | 1.280B |
| July 19, 2024 | 1.271B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
75.54M
Minimum
Oct 25 2023
1.746B
Maximum
Feb 27 2024
820.37M
Average
644.31M
Median
May 09 2023
Enterprise Value Benchmarks
| Koninklijke Philips NV | 35.10B |
| uniQure NV | -174.54M |
| ProQR Therapeutics NV | 51.16M |
| Merus NV | 2.469B |
| argenx SE | 28.96B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -39.01M |
| Revenue (Quarterly) | 2.279M |
| Total Expenses (Quarterly) | 53.68M |
| EPS Diluted (Quarterly) | -0.41 |
| Profit Margin (Quarterly) | -1.71K% |
| Earnings Yield | -15.10% |
| Normalized Earnings Yield | -12.51 |